These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. Roshandel D, Holliday KL, Pye SR, Ward KA, Boonen S, Vanderschueren D, Borghs H, Huhtaniemi IT, Adams JE, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, Thomson W, ONeill TW, EMAS Study Group. Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949 [Abstract] [Full Text] [Related]
3. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Shang M, Lin L, Cui H. Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404 [Abstract] [Full Text] [Related]
7. Polymorphisms in genes in the RANKL/RANK/OPG pathway are associated with bone mineral density at different skeletal sites in post-menopausal women. Tu P, Duan P, Zhang RS, Xu DB, Wang Y, Wu HP, Liu YH, Si L. Osteoporos Int; 2015 Jan; 26(1):179-85. PubMed ID: 25138264 [Abstract] [Full Text] [Related]
9. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". Piedra M, García-Unzueta MT, Berja A, Paule B, Lavín BA, Valero C, Riancho JA, Amado JA. BMC Med Genet; 2011 Dec 20; 12():168. PubMed ID: 22185226 [Abstract] [Full Text] [Related]
13. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia. Zheng H, Wang C, He JW, Fu WZ, Zhang ZL. Pharmacogenet Genomics; 2016 Jan 20; 26(1):12-9. PubMed ID: 26426211 [Abstract] [Full Text] [Related]
17. Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway. Mencej-Bedrač S, Zupan J, Mlakar SJ, Zavratnik A, Preželj J, Marc J. Drug Metabol Drug Interact; 2014 Jan 20; 29(2):111-4. PubMed ID: 24615483 [Abstract] [Full Text] [Related]
18. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. Wang J, Lu K, Song Y, Zhao S, Ma W, Xuan Q, Tang D, Zhao H, Liu L, Zhang Q. PLoS One; 2015 Jan 20; 10(7):e0133964. PubMed ID: 26218592 [Abstract] [Full Text] [Related]
19. The ESR1 (6q25) locus is associated with calcaneal ultrasound parameters and radial volumetric bone mineral density in European men. Holliday KL, Pye SR, Thomson W, Boonen S, Borghs H, Vanderschueren D, Gielen E, Huhtaniemi IT, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Wu FC, O'Neill TW, EMAS study group. PLoS One; 2011 Jan 20; 6(7):e22037. PubMed ID: 21760950 [Abstract] [Full Text] [Related]